BNP PARIBAS ARBITRAGE, SA
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1166588
NEW YORK, NY
Position in RARE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,633,796
+$6,351,893 QoQ
Shares Held
498,167
+1.5% QoQ
Ownership
0.505%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#43
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. RARE ranks #49 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,633,796 | 498,167 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,281,903 | 490,783 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $20,770,150 | 903,050 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $17,236,411 | 573,019 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,211,033 | 225,826 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,403,774 | 176,851 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,000,359 | 142,628 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,601,562 | 28,831 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,773,099 | 67,472 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $928,804 | 19,893 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $7,521,177 | 157,281 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,638,903 | 214,275 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,148,443 | 154,963 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $3,950,972 | 98,528 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,753,113 | 59,424 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,732,935 | 65,997 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $885,891 | 14,849 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,252,622 | 17,249 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $3,937,093 | 46,820 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $911,730 | 10,109 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $709,022 | 7,436 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,389,189 | 38,549 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $2,503,921 | 18,088 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,851,417 | 34,693 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $1,330,365 | 17,008 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $1,769,735 | 39,832 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||